return equiti ttm
freestyl libr medicar approv come earlier expect
thursday morn januari abbott market perform announc
receiv medicar approv freestyl libr flash glucos monitor fgm system
approv come six nine month earlier anticip believ
abbott broader presenc like expand patient awar given alert
alarm vulner patient popul remain product-of-
choic view estim achievableeven upsid less likelygiven earli
stage adopt cgm/fgm medicar popul penetr end
model pace ad patient end
model medicar patient add instal base
year-end equat roughli million revenu recal dexcom
referenc roughli patient backlog alreadi interest system
summer like grown sinc time roughli type
medicare-ag patient unit state base recent patient confer
attend believ interest remain high
still largest payer approv libr date would expect abbott
invest drive awar system patient popul howev
price system level adopt driven product featur rather
cost advantag
detail know rule page
near term believ grow world-wide sale
announc thursday morn chang view addit libr
marketplac medicar approv add uncertainti regard patient add
price remain believ categori abil multipl player win
long-term potenti market remain larg believ biggest
determin stock next sever year share trade time
revenu target million rate stock outperform
make continu glucos monitor provid real-tim blood glucos measur trend
display vari period sound alarm patient blood-glucos level stray outsid predefin
conclus stock thought
pleas refer import disclosur page analyst certif page
william blair affili seek busi compani cover research report
result investor awar firm may conflict interest could affect object
report report intend provid person invest advic opinion recommend
herein take account individu client circumst object need intend
recommend particular secur financi instrument strategi particular client recipi
report must make independ decis regard secur financi instrument mention
know approv
mean
libr fall current establish medicar reimburs code touch base abbott note libr
roll current establish medicar rule medicar administr contractor local coverag decis impli
product cover code reimburs dollar amount requir elig criteria approv
 price use way get approv modest posit keep player
cost level product featur like largest determin demand
libr go durabl medic equip dme medicar abbott list six differ domest dme provid libr
avail edgepark medic suppli solara medic suppli edward health servic better
live pharmaci togeth provid cover dme market also cover still
expect devic cost libr less dme may drive larger push toward one system take
time dynam becom clear though believ largest impact product choic patient physician
also approv coverag decis similar abbott establish presenc pcp gener rare
prescrib product repres fraction like patient add compani abbott certainli detail
product pcp endocrinologist believ creat increment market expans among pcp manag mani
type diabet unit state today particularli medicar age
despit approv thesi abil major share medicar market chang
studi shown impair awar hypoglycemia iah affect roughli peopl type diabet
durat diabet amount time patient live condit highli correl iah older patient get
like affect iah result elderli patient among vulner motiv use
continu glucos monitor cgm alert alarm view given frequenc peopl diabet
routin run low well risk seizur coma hospit death associ undetect low iah often life-
believ physician prescrib product patient like use gain benefit weigh
factor certain patient abbott easier-to-us simpler form factor eventu launch system alert
alarm may better option howev believ approv second product coverag like expand
patient choic therein adopt product marketplac
abbott still work get commerci payer approv current non-medicar patient need pay cash
pharmaci manag told us compani big commerci win date though success gain
smaller commerci contract still expect take time abbott work get major commerci insur
contract win end
even abbott secur commerci contract still believ number patient want true continu glucos
sensor alert alarm adopt datepotenti person reason career insur age
technolog versu mard insert devic patient recogn benefit addit capabl better
accuraci cgm provid note lower estim reflect freestyl libr impact chang may come
posit long term detail
check suggest endocrinologist posit libr type devic rather type devic
lack alert alarm continu connect reader see note patient diabet meet suggest strong interest
cgm libr view type product endocrinologist detail could posit dynam
cours
still exclus pediatr popul benefit compani abbott run trial
pediatr approv assum compani eventu receiv approv indic still believ parent valu
abil see child data via share featur place high import alert alarm provid sinc children
less disciplin like forget check blood sugar
anyth els know outsid medicar
one research analyst respons cover inc mention report own share secur
william blair affili benefici control either directli manag account equiti secur
inc end month end day date herein
william blair affili market maker secur inc
william blair affili expect receiv intend seek compens invest bank servic inc
affili within next three month
offic employe william blair affili research analyst may financi interest secur
inc
report avail electron form regist user via doc http //williamblairlibrari bluematrix com
pleas contact us consult williamblair com/research-and-insights/equity-research/coverag aspx disclosur
